Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jue-Hui Mao, Lu Han, Xiao-Qin Liu & Zheng Jiao. (2023) Significant predictors for olanzapine pharmacokinetics: a systematic review of population pharmacokinetic studies. Expert Review of Clinical Pharmacology 16:6, pages 575-588.
Read now
Read now
Marija Jovanović, Katarina Vučićević & Branislava Miljković. (2020) Understanding variability in the pharmacokinetics of atypical antipsychotics – focus on clozapine, olanzapine and aripiprazole population models. Drug Metabolism Reviews 52:1, pages 1-18.
Read now
Read now
Articles from other publishers (12)
Aya Mohammed, Wesam M. El-Bakly, Azza Ali & Ebtehal El-Demerdash. (2020) Rosuvastatin improves olanzapine’s effects on behavioral impairment and hippocampal, hepatic and metabolic damages in isolated reared male rats. Behavioural Brain Research 378, pages 112305.
Crossref
Crossref
Hee Ryung Wang, Young Sup Woo & Won-Myong Bahk. (2014) The potential role of atypical antipsychotics in the treatment of panic disorder. Human Psychopharmacology: Clinical and Experimental 29:5, pages 405-413.
Crossref
Crossref
Cecilia Mattsson, Theresa Andreasson, Nicholas Waters & Clas Sonesson. (2012) Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach. Journal of Medicinal Chemistry 55:22, pages 9735-9750.
Crossref
Crossref
W. Wolfgang Fleischhacker & Alex Hofer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
937
960
.
Marilyn A. DaviesYvette Conley & Bryan L. Roth. (2010)
Functional SNPs in Genes Encoding the 5-HT
2A
Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic Drugs
. Biological Research For Nursing 13:1, pages 55-60.
Crossref
Crossref
Roza Ghotbi, Buster Mannheimer, Eleni Aklillu, Akira Suda, Leif Bertilsson, Erik Eliasson & Urban Ösby. (2010) Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients. European Journal of Clinical Pharmacology 66:5, pages 465-474.
Crossref
Crossref
Gerard A. McLoughlinDan MaTsz M. TsangDeclan N. C. JonesJackie CiliaMark D. HillMelanie J. RobbinsIsabel M. BenzelPeter R. MaycoxElaine HolmesSabine Bahn. (2009)
Analyzing the Effects of Psychotropic Drugs on Metabolite Profiles in Rat Brain Using
1
H NMR Spectroscopy
. Journal of Proteome Research 8:4, pages 1943-1952.
Crossref
Crossref
Seung-Gul Kang, Heon-Jeong Lee, Young-Min Park, Jung-Eun Choi, Changsu Han, Yong-Ku Kim, Seung-Hyun Kim, Min-Soo Lee, Sook-Haeng Joe, In-Kwa Jung & Leen Kim. (2008) Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:1, pages 160-163.
Crossref
Crossref
W. Wolfgang Fleischhacker, Martina Hummer & Alex Hofer. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
847
872
.
Jonas Eberhard, Eva Lindström & Sten Levander. (2006) Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. International Clinical Psychopharmacology 21:1, pages 35-42.
Crossref
Crossref
Tsuyoshi Hirose, Yasufumi Uwahodo, Sakiko Yamada, Takashi Miwa, Tetsuro Kikuchi, Hisashi Kitagawa, Kevin D. Burris, C. Anthony Altar & Toshitaka Nabeshima. (2016) Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile. Journal of Psychopharmacology 18:3, pages 375-383.
Crossref
Crossref
Leon J. Dusci, L. Peter Hackett, Linda M. Fellows & Kenneth F. Ilett. (2002) Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. Journal of Chromatography B 773:2, pages 191-197.
Crossref
Crossref